Drug
Propiverine clinical trials
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2004 (3)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 3
APOGEPHA Arzneimittel GmbH (3) · Cairo University (1) · Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan (1) · Lee's Pharmaceutical Limited (1) · Samsung Medical Center (1) · Pfizer (1)
Related medicines
As reviewed, each with the page that says it.
- One of Cholinergic Antagonists source
- One of Muscarinic Antagonists source
- One of Parasympatholytics source
Studies
Open first, then newest update. How each study uses propiverine is read from its arms, and is right about nine times in ten.
Testing it · 8
- Effect of Interferential Electrical Stimulation on Pain Perception and Disability Level on Interstitial CystitisCompletedNot applicableCairo UniversityNCT03844581Written as Propiverine Hydrochloride
- Female Patients With Signs of uRgE and Stress Urinary Incontinence Study of Propiverine HydrochlorideCompletedNot applicableTranslational Research Center for Medical Innovation, Kobe, Hyogo, JapanNCT01942681Written as Propiverine Hydrochloride
- Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor OveractivityCompletedPhase 3APOGEPHA Arzneimittel GmbHNCT01530620Written as Propiverine hydrochloride ER (extended release)
- Propiverine Hydrochloride Extended-Release Capsule for Overactive BladderCompletedPhase 3Lee's Pharmaceutical LimitedNCT01512004Written as Propiverine Hydrochloride
- Urinary Urgency Outcomes Following Propiverine Treatment for an Overactive BladderCompletedPhase 4Samsung Medical CenterNCT00903045Written as Propiverine hydrochloride
- Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive BladderCompletedPhase 2APOGEPHA Arzneimittel GmbHNCT00795925Written as propiverine hydrochloride
- A Study to Evaluate the Efficacy of Tolterodine Prolonged Release Compared With Propiverine for the Treatment of Korean Patients With Overactive Bladder as Assessed by Ambulatory Urodynamic MonitoringCompletedPhase 3PfizerNCT00646880Written as propiverine
- Propiverine in Children Suffering From Non-Neurogenic Overactive Bladder and Urinary IncontinenceCompletedPhase 3APOGEPHA Arzneimittel GmbHNCT00603343Written as Mictonetten 5 mg, coated tablet
Given in every arm · 1 — propiverine is usual care beside what is tested
Codes
What other systems call propiverine · ClinicalTrials.gg INT002631
- MeSH (NLM) C015586propiverineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 468GE2241LPROPIVERINEConfirmed FDA, NLM, Wikidata
- RxNorm 55175Confirmed FDA, Wikidata
- Wikidata Q904321propiverineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66491PropiverineOne source FDA
- DrugBank DB12278One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C015586 | propiverine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 468GE2241L | PROPIVERINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 55175 | — | Confirmed FDA, Wikidata |
| Wikidata | Q904321 | propiverine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66491 | Propiverine | One source FDA |
| DrugBank | DB12278 | — | One source Wikidata |
Also registered as propiverine hydrochloride (UNII DC4GZD10H3 · RxNorm 55176).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.